Journal of the neurological sciences
Comment on "wearing-off symptoms persist in the majority of patients with multiple sclerosis after switching from natalizumab to ocrelizumab".
Bhumesh Tyagi, Leelabati Toppo, Aishwarya Biradar
Published: 202610.1016/j.jns.2025.125705
No abstract available for this study.